Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2012, Article ID 926931, 2 pages
http://dx.doi.org/10.1155/2012/926931
Editorial

Systemic Lupus Erythematosus: Genomics, Mechanisms, and Therapies

1Rheumatology Department, University of Málaga (UMA), Málaga, Spain
2Grup de Recerca de Reumatologia, Institut de Recerca, Hospital Vall d'Hebron, Barcelona, Spain
3Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL 35226, USA
4Centre for Rheumatology, Division of Medicine, University College London, London, UK

Received 31 May 2012; Accepted 31 May 2012

Copyright © 2012 Antonio Fernández-Nebro et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Danchenko, J. A. Satia, and M. S. Anthony, “Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden,” Lupus, vol. 15, no. 5, pp. 308–318, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Kyogoku, H. M. Dijstelbloem, N. Tsuchiya et al., “Fcγ receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility,” Arthritis and Rheumatism, vol. 46, no. 5, pp. 1242–1254, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. X. Li, J. Wu, R. H. Carter et al., “A novel polymorphism in the Fcgamma receptor IIB (CD32B) transmembrane region alters receptor signaling,” Arthritis and Rheumatism, vol. 48, no. 11, pp. 3242–3252, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. P. S. Patole, H. J. Gröne, S. Segerer et al., “Viral double-stranded RNA aggravates lupus nephritis through toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells,” Journal of the American Society of Nephrology, vol. 16, no. 5, pp. 1326–1338, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. C. G. Horton, Z. J. Pan, and A. D. Farris, “Targeting toll-like receptors for treatment of SLE,” Mediators of Inflammation, vol. 2010, Article ID 498980, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. H. J. Anders, V. Vielhauer, V. Eis et al., “Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice,” The FASEB Journal, vol. 18, no. 3, pp. 534–536, 2004. View at Google Scholar · View at Scopus
  7. P. S. Patole, R. D. Pawar, M. Lech et al., “Expression and regulation of Toll-like receptors in lupus-like immune complex glomerulonephritis of MRL-Fas(lpr) mice,” Nephrology Dialysis Transplantation, vol. 21, no. 11, pp. 3062–3073, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. H. R. Griffiths, “Is the generation of neo-antigenic determinants by free radicals central to the development of autoimmune rheumatoid disease?” Autoimmunity Reviews, vol. 7, no. 7, pp. 544–549, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Fujimoto, T. Kagoshima, T. Nakajima, and K. Dohi, “Doppler echocardiographic assessment of left ventricular diastolic function in patients with systemic lupus erythematosus,” Cardiology, vol. 85, no. 3-4, pp. 267–272, 1994. View at Google Scholar · View at Scopus